Safeguard Patients on Anticoagulants During Care Transitions

December 2021

You play a key role in ensuring safe use of anticoagulants during transitions of care.

Admission. Document doses and durations carefully.

Also confirm the indication, such as rivaroxaban 2.5 mg BID for peripheral artery disease... 10 mg daily for VTE prophylaxis...or 20 mg daily to prevent a stroke from atrial fibrillation or to treat a VTE.

Get concise advice on drug therapy, plus unlimited access to CE

Hospital Pharmacist's Letter membership benefits include:

12 issues every year — what you need to know and do, right now
Quick, practical reference charts and tools
Comprehensive CE library to meet license renewal and state requirements
Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
Plus much more!

Choose the right tier for your needs today.

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Stroke Compare Tenecteplase to Alteplase for Acute Ischemic Stroke
Anticoagulants Safeguard Patients on Anticoagulants During Care Transitions
CPR Review Processes for Using Crash Cart Meds Safely
COVID-19 Educate About COVID-19 Vaccination for Kids 5 and Up
Nephrology Clarify That CrCl and eGFR Are Not Interchangeable
Vaccines Be Familiar With New Pneumococcal Vaccines
Med Administration Teach Patients to Self-Inject Subcutaneous or IM Meds
Antipsychotics Navigate Antipsychotic Side Effects
Neurology & Pain Emphasize Nondrug Strategies After a Concussion
Ophthalmology Watch for Rx Tyrvaya, a New Nasal Spray for Dry Eye
Med Safety Use ENFit Low-Dose Tip Syringes Properly

Safeguard Patients on Anticoagulants During Care Transitions

Get concise advice on drug therapy, plus unlimited access to CE

Table of Contents